Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11782858 | 1.00 | GPR84 (0.50) | GPR84FFAR1FAAHFFAR4ZDHHC7 | |
| SCHEMBL8666568 | 1.00 | GPR84 (0.50) | GPR84FFAR1FAAHFFAR4ZDHHC7 | |
| SCHEMBL11782957 | 1.00 | GPR84 (0.50) | GPR84FFAR1FAAHFFAR4ZDHHC7 | |
| SCHEMBL11782571 | 1.00 | GPR84 (0.50) | GPR84FFAR1FAAHFFAR4ZDHHC7 | |
| SCHEMBL11785027 | 1.00 | GPR84 (0.50) | GPR84FFAR1FAAHFFAR4ZDHHC7 | |
| SCHEMBL11784604 | 1.00 | GPR84 (0.50) | GPR84FFAR1FAAHFFAR4ZDHHC7 | |
| SCHEMBL11778914 | 1.00 | GPR84 (0.50) | GPR84FFAR1FAAHFFAR4ZDHHC7 | |
| SCHEMBL9250546 | 0.98 | GPR84 (0.47) | GPR84FFAR1FAAHFFAR4ZDHHC7 | |
| Methoxymethane SCHEMBL3379495 | 0.94 | GPR84 (0.44) | GPR84FFAR1FAAHFFAR4ZDHHC7 | |
| SCHEMBL861395 | 0.91 | ALDH1A1 (0.43) | GPR84FFAR1FAAHPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050143599-A1 | Process for preparing monoesters | 3M INNOVATIVE PROPERTIES COMPANY | 2005-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143599-A1 | Process for preparing monoesters | ADSL, COASY, AGPS | GPR84 1658/4885FFAR1 556/4885FAAH 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.